financetom
Business
financetom
/
Business
/
Atlassian Insider Sold Shares Worth $1,521,715, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Atlassian Insider Sold Shares Worth $1,521,715, According to a Recent SEC Filing
Jun 26, 2025 1:18 AM

03:45 AM EDT, 06/26/2025 (MT Newswires) -- Michael Cannon-Brookes, 10% Owner, Director, Chief Executive Officer, Co-Founder, on June 24, 2025, sold 7,665 shares in Atlassian ( TEAM ) for $1,521,715. Following the Form 4 filing with the SEC, Cannon-Brookes has control over a total of 30,660 Class A common shares of the company, with 30,660 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1650372/000156218025005076/xslF345X05/primarydocument.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cat Victory Over Dogs? Popcat Rally Defies Dogecoin, Shiba Inu Decline, Coin's YTD Gains Skyrocket 15344%
Cat Victory Over Dogs? Popcat Rally Defies Dogecoin, Shiba Inu Decline, Coin's YTD Gains Skyrocket 15344%
Oct 22, 2024
Cat-themed Popcat (POPCAT) shrugged off declines in the meme coin space to emerge as one of the market's biggest gainers on Tuesday. What happened: The Solana (CRYPTO: SOL)–based coin rose 5.63% in the last 24 hours, becoming the second-best-performing cryptocurrency in the market.  The billion-dollar capitalization coin saw its trading volume surge 44% in the 24-hour interest, indicating significant demand....
Roche Q3 sales advance by forex-adj 9%, beating market view
Roche Q3 sales advance by forex-adj 9%, beating market view
Oct 22, 2024
FRANKFURT (Reuters) -Roche's third-quarter sales gained a currency-adjusted 9%, beating market expectations, on higher prescriptions of once-monthly haemophilia shot Hemlibra and recently launched eye drug Vabysmo. Group sales of 15.14 billion Swiss francs ($17.46 billion) surpassed an analysts' consensus estimate of 14.9 billion francs, based on LSEG data. The Swiss drugmaker reaffirmed on Wednesday it expects growth in 2024 adjusted...
Roche Q3 sales advance by forex-adj 9%, beating market view
Roche Q3 sales advance by forex-adj 9%, beating market view
Oct 22, 2024
FRANKFURT, Oct 23 (Reuters) - Roche on Wednesday said that third-quarter sales gained a currency-adjusted 9% to 15.14 billion Swiss francs ($17.46 billion). That surpassed an analysts' consensus estimate of 14.9 billion francs, based on LSEG data. ($1 = 0.8671 Swiss francs) ...
Volvo Cars cuts full-year growth outlook on market slowdown
Volvo Cars cuts full-year growth outlook on market slowdown
Oct 22, 2024
STOCKHOLM (Reuters) - Sweden-based Volvo Cars reported a rise in third-quarter operating profit on Wednesday but cut its full-year sales growth forecast amid accelerating market weakness. Volvo Cars said it now expects to grow its retail sales by between 7-8% this year, down from a previous outlook from July of 12-15% growth. Operating profit at the company, which is majority-owned...
Copyright 2023-2026 - www.financetom.com All Rights Reserved